Chevalier Kevin, Hamroun Sabrina, Bitoun Samuel, Henry Julien, Roux Christian, Briot Karine, Belkhir Rakiba, Mariette Xavier, Seror Raphaèle
Department of Rheumatology, Université Paris-Saclay, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
Department of Rheumatology, Université Paris-Cité, Assistance Publique-Hôpitaux de Paris (AP-HP), CHU Cochin, Paris, France.
Bone Rep. 2024 Mar 25;21:101755. doi: 10.1016/j.bonr.2024.101755. eCollection 2024 Jun.
Multiple myeloma (MM) frequently causes vertebral fractures (VF). Some are lytic lesions and others have the aspect of benign osteoporotic fractures not requiring anti-myeloma treatment. We explored outcome of these patients with smoldering myeloma (SM) and osteoporotic VF. In this retrospective bi-centric study, patients were identified using a systematic keyword search on electronic medical records. Patients with SM and isolated VF of osteoporotic aspect without indications for myeloma-specific therapy were included. Overall, 13 (7 %) of the 184 identified patients had SM and VF confirmed to be osteoporotic (median number of VF was 3). During follow-up, 12 (92 %) patients evolved to symptomatic MM, 7 (54 %) of them within 18 months (early progressors). Myeloma defining events were new lytic bone lesions in 7 patients (53.8 %). The serum calcium level was significantly higher in the early progressor group (median 2.35 IQR [2.31-2.38] and 2.28 IQR [2.21-2.29] respectively, = 0.003). Early progressors had a higher number of VF at diagnosis (3.0 [2.0-5.5] vs 1.0 [1.0-2.5], = 0.18) and more frequently evolved to symptomatic MM because of lytic bone lesions (5 [71 %] vs 2 [33 %], = 0.13) compared to late progressors. VF of osteoporotic appearance in the context of SM is a rare situation but at high risk of rapid progression to symptomatic MM, suggesting that they may represent bone fragility linked to MM infiltration rather than solely osteoporotic fractures. Further studies are needed to assess if earlier treatment might be beneficial in this population.
多发性骨髓瘤(MM)常导致椎体骨折(VF)。有些是溶骨性病变,而其他则表现为良性骨质疏松性骨折,无需进行抗骨髓瘤治疗。我们探讨了这些冒烟型骨髓瘤(SM)和骨质疏松性VF患者的预后。在这项回顾性双中心研究中,通过对电子病历进行系统的关键词搜索来识别患者。纳入了患有SM且孤立性骨质疏松性VF且无骨髓瘤特异性治疗指征的患者。总体而言,在184例识别出的患者中,有13例(7%)患有SM且VF被确认为骨质疏松性(VF的中位数为3)。在随访期间,12例(92%)患者进展为有症状的MM,其中7例(54%)在18个月内进展(早期进展者)。骨髓瘤定义事件为7例患者(53.8%)出现新的溶骨性骨病变。早期进展者组的血清钙水平显著更高(中位数分别为2.35四分位数间距[2.31 - 2.38]和2.28四分位数间距[2.21 - 2.29],P = 0.003)。与晚期进展者相比,早期进展者在诊断时的VF数量更多(3.0[2.0 - 5.5]对1.0[1.0 - 2.5],P = 0.18),并且因溶骨性骨病变更频繁地进展为有症状的MM(5例[71%]对2例[33%],P = 0.13)。SM背景下骨质疏松外观的VF是一种罕见情况,但快速进展为有症状MM的风险很高,这表明它们可能代表与MM浸润相关的骨脆性,而非单纯的骨质疏松性骨折。需要进一步研究来评估在此人群中更早治疗是否有益。